DASH could effectively enrich for a rare mutant variant of the KRAS gene in synthetic gDNA mixtures with a guide sequence against wild-type KRAS, mimicking the situation where rare cancer cells need to be detected in a pool of normal cells (39). The gene discussed is KRAS; the disease is cancer.